Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium

Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium

Cellular cardiomyoplasty is an attractive option for the treatment of severe heart failure. It is, however, still unclear and controversial which is the most promising cell source. Therefore, we investigated and examined the fate and functional impact of bone marrow (BM) cells and embryonic stem cel...

Full description

Bibliographic Details
Main Authors: Kolossov, Eugen, Bostani, Toktam, Roell, Wilhelm, Breitbach, Martin, Pillekamp, Frank, Nygren, Jens M., Sasse, Philipp, Rubenchik, Olga, Fries, Jochen W. U., Wenzel, Daniela, Geisen, Caroline, Xia, Ying, Lu, Zhongju, Duan, Yaqi, Kettenhofen, Ralf, Jovinge, Stefan, Bloch, Wilhelm, Bohlen, Heribert, Welz, Armin, Hescheler, Juergen, Jacobsen, Sten Eirik, Fleischmann, Bernd K.
Format: Online
Language:English
Published: The Rockefeller University Press 2006
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118112/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118112/

Similar Items